Abstract
Human medicines European public assessment report (EPAR): Hycamtin, topotecan, Ovarian Neoplasms,Uterine Cervical Neoplasms,Small Cell Lung Carcinoma, Date of authorisation: 12/11/1996, Revision: 30, Status: Authorised
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have